Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011;6(7):e21008.
doi: 10.1371/journal.pone.0021008. Epub 2011 Jul 26.

Treatment outcome and mortality at one and half year follow-up of HIV infected TB patients under TB control programme in a district of South India

Sophia Vijay  1 , Prahlad Kumar, Lakbir Singh Chauhan, Saroja Vadigepalli Narayan Rao, Preetish Vaidyanathan
Affiliations

Treatment outcome and mortality at one and half year follow-up of HIV infected TB patients under TB control programme in a district of South India

Sophia Vijay et al. PLoS One. 2011.

Abstract

Background: There is paucity of data from India on the impact of HIV related immunosuppression in response to TB treatment and mortality among HIV infected TB patients. We assessed the TB treatment outcome and mortality in a cohort of HIV infected TB patients treated with intermittent short course chemotherapy under TB control programme in a high HIV prevalent district of south India.

Methodology/ findings: Among 3798 TB patients registered for treatment in Mysore district from July 2007 to June 2008, 281 HIV infected patients formed the study group. The socio-demographic and treatment related data of these patients was obtained from TB and HIV programme records and patient interviews 19 months after TB treatment initiation by field investigators. Treatment success rate of 281 patients was 75% while in smear positive pulmonary tuberculosis cases it was 62%, attributable to defaults (16%) and deaths (19%). Only 2 patients had treatment failure. Overall, 83 (30%) patients were reported dead; 26 while on treatment and 57 after TB treatment. Association of treatment related factors with treatment outcome and survival status was studied through logistic regression analysis. Factors significantly associated with 'unfavourable outcome' were disease classification as Pulmonary [aOR-1.96, CI (1.02-3.77)], type of patient as retreatment [aOR-4.78, CI (2.12-10.76)], and non initiation of ART [aOR-4.90, CI (1.85-12.96)]. Factors associated with 'Death' were non initiation of ART [aOR-2.80, CI (1.15-6.81)] and CPT [aOR-3.46, CI (1.47-8.14)].

Conclusion: Despite the treatment success of 75% the high mortality (30%) in the study group is a matter of concern and needs immediate intervention. Non initiation of ART has emerged as a high risk factor for unfavourable treatment outcome and mortality. These findings underscore the importance of expanding and improving delivery of ART services as a priority and reconsideration of the programme guidelines for ART initiation in HIV infected TB patients.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Interview coverage of the study group.
See this image and copyright information in PMC

References

    1. Narain JP, Raviglione MC, Kochi A. HIV associated tuberculosis in developing countries: Epidemiology and strategies for prevention. Tuberc Lung Dis. 1992;73:311–21. - PubMed
    1. Singh A, Bairy I, Shivananda PG. Spectrum of opportunistic infections in AIDS cases. Indian J Med Sci. 2003;57:16–21. - PubMed
    1. Girardi E, Raviglione MC, Antonucci G, et al. Impact of the HIV epidemic on the spread of other diseases: the case of tuberculosis. AIDS. 2000;14(suppl 3):S47–S56. - PubMed
    1. Corbett EK, Watt CJ, Walker N, Maher D, Williams BG, et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic burden of tuberculosis. Arch Intern Med. 2003;163:1009–1021. - PubMed
    1. Harries AD. TB and HIV in developing countries. Lancet. 1990;334:387. - PubMed

Publication types

MeSH terms

Substances